Palermo, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 13.992
NA - Nord America 2.745
AS - Asia 1.733
SA - Sud America 323
AF - Africa 78
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 18.892
Nazione #
IT - Italia 11.266
US - Stati Uniti d'America 2.635
SG - Singapore 764
NL - Olanda 762
DE - Germania 657
CN - Cina 369
SE - Svezia 330
FR - Francia 256
BR - Brasile 252
VN - Vietnam 162
GB - Regno Unito 141
UA - Ucraina 132
IN - India 108
IE - Irlanda 83
CA - Canada 73
CH - Svizzera 65
BD - Bangladesh 53
ID - Indonesia 53
FI - Finlandia 43
JP - Giappone 42
RU - Federazione Russa 39
ES - Italia 37
PL - Polonia 37
BE - Belgio 32
HK - Hong Kong 32
TR - Turchia 28
AR - Argentina 26
MX - Messico 21
IQ - Iraq 16
MA - Marocco 15
AL - Albania 14
NG - Nigeria 13
ZA - Sudafrica 13
AT - Austria 12
AU - Australia 12
EC - Ecuador 12
RO - Romania 11
EG - Egitto 10
GR - Grecia 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
PK - Pakistan 9
AZ - Azerbaigian 8
CL - Cile 8
HU - Ungheria 8
JO - Giordania 8
KR - Corea 8
TH - Thailandia 8
TN - Tunisia 8
VE - Venezuela 8
LT - Lituania 7
PA - Panama 7
CZ - Repubblica Ceca 6
IL - Israele 6
PT - Portogallo 6
TW - Taiwan 6
EU - Europa 5
NP - Nepal 5
PE - Perù 5
PH - Filippine 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
CO - Colombia 4
HR - Croazia 4
RS - Serbia 4
SA - Arabia Saudita 4
SM - San Marino 4
UZ - Uzbekistan 4
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
KG - Kirghizistan 3
MD - Moldavia 3
MY - Malesia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
CV - Capo Verde 2
DZ - Algeria 2
IS - Islanda 2
KE - Kenya 2
LK - Sri Lanka 2
MT - Malta 2
NO - Norvegia 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UG - Uganda 2
UY - Uruguay 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IM - Isola di Man 1
Totale 18.879
Città #
Milan 1.062
Rome 822
Singapore 404
Naples 358
Chandler 347
Ashburn 312
San Jose 244
Turin 215
Florence 185
Bologna 154
Palermo 142
Bari 125
Catania 105
Genoa 99
Los Angeles 98
Beijing 79
Dublin 79
Verona 79
New York 77
Jacksonville 75
Ann Arbor 73
San Mateo 69
Ho Chi Minh City 62
Wilmington 58
Brescia 56
The Dalles 54
Frankfurt am Main 51
Venice 49
Jakarta 48
Lauterbourg 46
Padova 45
Nanjing 43
Cagliari 41
Parma 40
Reggio Emilia 40
Bergamo 39
Taranto 39
Pescara 38
Messina 36
Munich 35
Bremen 32
Perugia 32
Dearborn 31
Hefei 31
Salerno 30
São Paulo 30
Hanoi 29
Tokyo 29
Boston 28
Dallas 28
Hong Kong 28
Livorno 28
Ottawa 28
Buffalo 25
Cattolica 25
Hyderabad 25
Lucca 25
Brussels 24
Chicago 24
Marseille 24
Nürnberg 24
Redwood City 24
Rimini 24
Modena 23
Monza 23
Santa Clara 23
Amsterdam 22
Lawrence 22
Moscow 21
Woodbridge 21
Novara 20
Trieste 20
Houston 18
Falls Church 16
Nanchang 16
Princeton 16
Brooklyn 15
Lancaster 15
Seattle 15
Vicenza 15
Atlanta 14
Caserta 14
Lecce 14
Montreal 14
Tianjin 14
Zurich 14
Tirana 13
Toronto 13
Cesano Maderno 12
Chennai 12
Council Bluffs 12
Piacenza 12
Porto Sant'Elpidio 12
Trento 12
Catanzaro 11
Denver 11
Helsinki 11
Lamezia Terme 11
Macerata 11
Manchester 11
Totale 7.220
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.157
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 433
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 319
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 203
Urological complications following inguinal hernioplasty 199
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 186
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 186
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 179
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 172
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 171
Hot topics in urological health economics. A mini review 168
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 166
Therapeutic strategies in penile cancer: state of the art 164
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 164
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 163
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 157
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 151
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 150
Imaging in prostate cancer staging: present role and future perspectives 145
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 145
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 141
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 138
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 133
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 132
The occult urothelial cancer 132
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 132
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 131
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 131
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 129
Focal surgery in testis cancer: current state of the art 127
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 120
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 115
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 113
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 112
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 112
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 108
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 105
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 103
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 102
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 102
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 99
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 94
[Sport, infertility and erectile dysfunction] 91
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 87
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer 81
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment 75
Bladder tumor markers: A review of the literature 75
Imaging in bladder cancer: Present role and future perspectives 60
Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions 6
Totale 18.988
Categoria #
all - tutte 39.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022464 38 29 5 38 36 35 15 62 26 37 69 74
2022/20232.159 173 150 88 196 85 180 98 181 228 174 351 255
2023/20244.326 258 336 300 332 323 346 369 399 343 431 438 451
2024/20256.068 471 574 579 527 605 485 507 516 630 414 442 318
2025/20264.319 590 266 304 403 590 281 648 294 299 271 216 157
2026/2027148 148 0 0 0 0 0 0 0 0 0 0 0
Totale 18.988